#Japan #Tsukuba #Kyoritsu Pharmaceutical #Welfare Building

Kyoritsu Pharmaceutical Enhances Employee Environment in Tsukuba

Kyoritsu Pharmaceutical Co., Ltd., headquartered in Chiyoda, Tokyo, is excited to announce the completion of a new welfare building at its advanced technology development center in Tsukuba, Ibaraki Prefecture, scheduled for April 2025. This facility aims to elevate the working environment for employees under the concept of 'Creating and Transforming' (INCUBATION), offering a safe and collaborative space for employees across different departments.

Background and Future Outlook

The construction of the welfare building is driven by the commitment to improve employee welfare and enhance interdepartmental communication. The space will serve as a melting pot for various departments, including research and development, production, and business promotion, ultimately leading to improved product development quality. Future expansions at the Tsukuba site will include the completion of a new research building and manufacturing equipment enhancements.

Three Key Features of the Welfare Building

1. Column-Free Spacious Office Space
Designed with an open layout, the lack of columns allows for flexible arrangements, fostering creative working styles.

2. User-Friendly Design for All Employees
The building incorporates universal design principles, featuring multi-functional restrooms and elevators that cater to all employees.

3. Aesthetics Encouraging Creativity
Emphasizing an 'unfinished' interior design, the building invites employees to 'nurture' the space, stimulating creativity and personal expression.

Environmental Considerations and Technical Innovations

In efforts to reduce environmental impact, the welfare building incorporates an 'Egg Wall' made from recycled eggshells in part of its interior design. This initiative symbolizes Kyoritsu's commitment to environmental sustainability while recognizing the significance of the eggs utilized in many of the company's daily processes.

The Egg Wall material boasts excellent moisture-absorption and odor-absorbing properties, and it offers easy maintenance. Notably, any substances causing egg allergies have been removed during production to ensure safety.

Commitment to Sustainable Future

As Kyoritsu Pharmaceutical approaches its 70th anniversary in 2025, the company remains dedicated to fostering a society where animals and humans coexist harmoniously through pet socialization initiatives and the sustainable development of livestock and aquaculture industries. By providing an environment where every employee can work with pride, Kyoritsu aims to grow as a professional entity through the spirit of craftsmanship.

Overview of the Welfare Building

• - Location: 2-9-22 Takamihara, Tsukuba City, Ibaraki Prefecture (within Kyoritsu Pharmaceutical Tsukuba Site)
• - Building Area / Total Floor Area: Approximately 500㎡
• - Structure and Scale: Steel-framed, two stories
• - Facilities: Offices, lounge areas, shared spaces, and more
• - Construction Period: Started June 2024, completed April 2025

About Kyoritsu Pharmaceutical Co., Ltd.

Founded in 1955, Kyoritsu Pharmaceutical is a leading company in animal healthcare, dedicated to the mission of 'Creating Pathways for Animals and Humans.' The company specializes in developing, manufacturing, marketing, and exporting veterinary pharmaceuticals for pets, livestock, and aquaculture.

• - Company Name: Kyoritsu Pharmaceutical Co., Ltd.
• - CEO: Takashi Takai
• - Established: May 1955
• - Capital: 55 million yen
• - Number of Employees: 733 (as of May 2024)
• - Business Activities: Development, manufacturing, and sales of animal pharmaceuticals and related products
• - Website: Kyoritsu Pharmaceutical